South Sudan received its first consignment of 152,950 doses of the Johnson & Johnson ‘Janssen’ COVID-19 vaccines on Tuesday. These single-dose Johnson & Johnson COVID-19 vaccines are the third batch of vaccine shipments to South Sudan through the COVAX Facility.
“Thanks to the United States Government, the vaccines will ramp up the ongoing COVID-19 vaccination programme to prevent COVID-19 in individuals 18 years of age and older”, said Minister of Health Elizabeth Achuei. “The Johnson & Johnson vaccine is the second vaccine in South Sudan’s programme, while the double-dose AstraZeneca vaccines have already been administered in the country.”
The arrival of the Johnson and Johnson vaccine means that the country has now received a total of 271,200 COVID-19 vaccine doses that are for providing protection against this global COVID-19 pandemic.
“The Johnson and Johnson vaccines that arrived today in South Sudan will offer an important contribution in the roll-out of COVID vaccines by the convenience of a one-shot dose, this will help to reach hard to reach areas of South Sudan and further accelerate the journey back to normalcy, said Jesper Moller, UNICEF Deputy Representative. “Protecting health workers, teachers and other delivering key social services is key to secure the continuation of services for children. We thank the US government and the COVAX facility. This delivery demonstrates the power of partnership.”